Morphine in acute coronary syndrome and myocardial infarction: pro et contra
-
Published:2021-09-19
Issue:1
Volume:3
Page:13-29
-
ISSN:2712-7648
-
Container-title:Health, Food & Biotechnology
-
language:
-
Short-container-title:jour
Author:
Ignatenko Grigoriy A.1ORCID, Taradin Gennadiy G.2ORCID, Rakitskaya Irina V.1ORCID, Gnilitskaya Viktoriya B.1ORCID, Kulikova Svetlana O.1
Affiliation:
1. State Educational Organization of Higher Professional Education “M. Gorky Donetsk National Medical University” 2. State Educational Organization of Higher Professional Education “M. Gorky Donetsk National Medical University”;
State Institution “Institute of Urgent and Reconstructive Surgery named after V.K. Gusak”
Publisher
Moscow State University of Food Production
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference51 articles.
1. Amsterdam, E.A., Wenger, N.K., Brindis, R.G., Casey, D.E., Ganiats, T.G., Holmes, D.R., Jaffe, A.S., Jneid, H., Kelly, R.F., Kontos, M.C., Levine, G.N., Liebson, P.R., Mukherjee, D., Peterson, E.D., Sabatine, M.S., Smalling, R.W., & Zieman, S.J. (2014). 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: A report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation, 130, e344-426. http://doi.org/10.1161/CIR.0000000000000134 2. Angiolillo, D.J., Schneider, D.J., Bhatt, D.L., French, W.J., Price, M.J., Saucedo, J.F., Shaburishvili, T., Huber, K., Prats, J., Liu, T., Harrington, R.A., & Becker, R.C. (2012). Pharmacodynamic effects of cangrelor and clopidogrel: The platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trials. Journal of Thrombosis and Thrombolysis, 34, 44-55. http://doi.org/10.1007/s11239-012-0737-3 3. Batchelor, R., Liu, D.H., Bloom, J., Noaman, S., & Chan, W. (2020). Association of periprocedural intravenous morphine use on clinical outcomes in ST‐elevation myocardial infarction (STEMI) treated by primary percutaneous coronary intervention: Systematic review and meta‐analysis. Catheterization and Cardiovascular Interventions, 96, 76-88. http://doi.org/10.1002/ccd.28561 4. Bhatt, D.L., Stone, G.W., Mahaffey, K.W., Gibson, C.M., Steq, P.G., Hamm, C.W., Price, M.J., Leonardi, S., Gallup, D., Bramucci, E., Radke, P.W., Widimsky, P., Tousek, F., Tauth, J., Spriqqs, D., McLaurin, B.T., Anqiolillo, D.J., Genereux, P., Liu, T., Pratz, J., Todd, M., Skerjanec, S., White, H.D., & Harrinqton, R.A. (2013). Effect of platelet inhibition with cangrelor during PCI on ischemic events. New England Journal of Medicine, 368, 1303-1313. http://doi.org/10.1056/NEJMoa1300815 5. Burduk, P., Guzik, P., Piechocka, M., Bronisz, M., Rozek, A., Jazdon, M., & Jordan, M.R. (2000). Comparison of fentanyl and droperidol mixture (neuroleptanalgesia II) with morphine on clinical outcomes in unstable angina patients. Cardiovascular Drugs and Therapy, 14, 259-269. http://doi.org/10.1023/a:1007826506825
|
|